Skip to main content
. 2017 Mar 9;1(4):317–322. doi: 10.1210/js.2017-00071

Table 1.

Clinical and Biological Characteristics Before Surgery and at the Indicated Years of Follow-Up

Duration of Follow-Up Baseline 6 Months 1 Year 1.5 Years 2 Years 3 Years
Body weight and body composition
 Body weight (kg) 108.5 86.4 81.7 71.8 80.8 73.0
 BMI (kg/m2) 40.8 32.5 30.8 27.0 30.4 27.5
 Fat-free mass (kg) 57.2 48.8 47.2 43.1 45.2
 Fat mass (kg) 51.3 37.6 34.5 28.7 35.6
 Fat mass (% body weight) 47.3 43.5 42.2 40.0 44.0
 Subcutaneous fat area (cm2) 526 407 297
 Visceral fat area (cm2) 362 183 186
Glucose homeostasis
 HbA1c (%) 7.8 6.2 6.9 6.9 9.8 7.1
 Fasting plasma glucose (mg/dL) 234 144 118 124 172 148
 Fasting insulin (μUI/mL) 73 34 20 21 28
 Fasting C-peptide (ng/mL) 9.9 5.9 4.7 4.6 6.1
 HOMA (%B) 98 118 138 125 92
 HOMA (%S) 10 20 27 27 18
 Matsuda index 0.43 1.00 1.87 1.62
 Insulinogenic index 0 0 0.24 0.27
Resting energy expenditure
 Measured value (kcal/24 h) 1853 1145 1281
 Percentage predicted (%) 114 78 93
Activity (kcal/24 h) 172 232
 Total cholesterol (mg/dL) 176 147 136 157 184 180
 HDL cholesterol (mg/dL) 41 42 30 36 34 52
 LDL cholesterol (mg/dL) 89 65 79 80 108 103
 Triglycerides (mg/dL) 229 196 135 203 211 129
 Creatinine (mg/dL) 1.3 1.0 1.2 1.0 1.3 1.2
 Creatinine clearance (mL/min) 43 68 79 82 68
 Liver volume (mL) 3210 1967 1916 1467
 Liver density (HU) 19 53 45 55
 Fibroscan (kPa) 11.7 4.6 5.8
 GGT (U/L) 89 44 69 38 34 43
Clinical features
 Systolic BP (mm Hg) 140 130 100 100 120 110
 Diastolic BP (mm Hg) 90 85 60 60 80 70

Abbreviations: BP, blood pressure; BW, body weight; GGT; Gamma Glutamyl Transferase; HDL, high-density lipoprotein; HOMA (%B), Homeostasis Model Assessment of beta cell function as percentage of a normal reference population; HOMA (%S), Homeostasis Model Assessment of insulin sensitivity as percentage of a normal reference population; HU, Hounsfield units; kPa, kilopascal; LDL, low-density lipoprotein; U/L, units per liter.